Daiwa Pharmaceutical Co., Ltd. [News Release]

"NKCP" appears on hit TV programmes.

Two hit TV programmes have successively publicised "NKCP", developed by Daiwa Pharmaceutical Co. Ltd. As a result of the current boom in fermented soybeans both inside and outside the country, the media including television have been vying with each other to feature fermented soybeans and nattokinase. It is already well known that nattokinase, which was discovered by Professor Hiroyuki Sumi of Kurashiki University of Science and the Arts, possesses fibrinolytic activity.
Media coverage is pouring in, not only because of the breakthrough that Daiwa's "NKCP" does not have the features peculiar to fermented soybeans of stickiness and odour, but also because the effects of this product serve as its reputation.
On "News Plus One" (28 national networks) on Friday, June 29th, 2001 broadcast on Nippon Television Network (NTV), the demonstration that Daiwa's NKCP can lyse a fibrin clot were broadcast in order to prove the power of Nattokinase. This report was filmed at the laboratory in the Tsukuba plant.
Moreover, this demonstration was also announced on the popular program "Aru Aru Daijiten (in Japanese)" (produced by the Kansai television) of Fuji Television (CX) on Sunday, September 23. This was also filmed at the Tsukuba laboratory. Since it is very unusual for the image of fibrin lysing to be shown on TV, this publicity has boosted its reputation considerably in the media.
Moreover, through being reported on such TV shows, NKCP has come to be widely recognised throughout the entire country, and it has also shown that it is the mainstream nattokinase supplement.

・